GATC Biotech AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:GATC Biotech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014175
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GATC Biotech AG (GATC Biotech) is a healthcare service center that offers sequencing services. The center products category include nextgen, liquid biopsy, tissue biopsy, sanger and cell culture. It offers nextgen products such as inview transcriptome, inview metagenome, inview microbiome, inview amplicon, inview de novo genome, inview modification analysis and inview epigenome. GATC Biotech provides Sanger sequencing services such as SUPREMErun, LIGHTrun sequencing, and NightXpress services. The center solutions include sequencing solutions, customized solutions and diagnostic solutions. It serves academic and industrial customers worldwide. Its partner portfolio includes Agilent Technologies, Applied Biosystems, BioLago, Cytobox, Roche, Illumina, Trenzyme and Macherey-Nagel. The company distributes its products in Italy, Japan, Portugal, Spain Turkey and Czech Republic. GATC is headquartered in
Constance, Germany.

GATC Biotech AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GATC Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GATC Biotech AG, Medical Devices Deals, 2011 to YTD 2017 8
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
GATC Biotech AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
GATC Biotech Enters into Agreement with University of Konstanz 10
Qiagen Enters into Agreement with GATC Biotech 11
Acquisition 12
Eurofins Scientific to Acquire GATC Biotech 12
GATC Biotech AG – Key Competitors 13
GATC Biotech AG – Key Employees 14
GATC Biotech AG – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
Jun 09, 2016: Liquid biopsy test – GATCLIQUID ONCOTARGET – expanded to cover blood cancers such as acute myeloid leukaemia 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
GATC Biotech AG, Pharmaceuticals & Healthcare, Key Facts 2
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GATC Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GATC Biotech AG, Medical Devices Deals, 2011 to YTD 2017 8
GATC Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
GATC Biotech Enters into Agreement with University of Konstanz 10
Qiagen Enters into Agreement with GATC Biotech 11
Eurofins Scientific to Acquire GATC Biotech 12
GATC Biotech AG, Key Competitors 13
GATC Biotech AG, Key Employees 14
GATC Biotech AG, Other Locations 15
GATC Biotech AG, Subsidiaries 15

★海外企業調査レポート[GATC Biotech AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VistaGen Therapeutics Inc (VTGN):製薬・医療:M&Aディール及び事業提携情報
    Summary VistaGen Therapeutics Inc (VistaGen) is a biopharmaceutical company that develops new generation medicines for neuropsychiatric disorders. The company’s product includes AV-101, which is a oral antidepressant which is currently under clinical study in National Institute of Mental Health (NIM …
  • Golden Gate Capital:企業の戦略的SWOT分析
    Golden Gate Capital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Kadmon Corp LLC-製薬・医療分野:企業M&A・提携分析
    Summary Kadmon Corp LLC (Kadmon) is a biopharmaceutical company that offers products and related services for the management and treatment of hepatitis C. The company also develops therapies for metabolic and serious diseases. Its products include ribavirin, USP Tablets, ribavirin capsules, phenterm …
  • Power Assets Holdings Ltd (6):石油・ガス:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • CohBar Inc (COB.U):企業の財務・戦略的SWOT分析
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Futuren (FTRN):電力:M&Aディール及び事業提携情報
    Summary Futuren, previously Theolia SA, is a wind energy producer that prospects, develops, constructs, installs and operates wind power projects. It specializes in designing and building onshore wind plants. Futuren conducts these operations for its own account as well as for third parties. The com …
  • Reach PLC:企業の戦略・SWOT・財務分析
    Reach PLC - Strategy, SWOT and Corporate Finance Report Summary Reach PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Landstar System, Inc.:企業の戦略・SWOT・財務分析
    Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report Summary Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Unicharm Corporation (8113):企業の財務・戦略的SWOT分析
    Unicharm Corporation (8113) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a biotechnology company which focuses on research, development and commercialization of novel products that prevent and remove biofilm related infections in humans and animals. The company’s products include StrixNB and Vetradent water additive, oral spray, …
  • Idacorp Inc (IDA):企業の財務・戦略的SWOT分析
    Summary Idacorp Inc (Idacorp) is an electric utility that distributes, markets, generates and purchases electricity. The utility owns natural gas-fired power plants and in coal-fired generating stations. It offers real estate investments and housing projects. Idacorp owns three coal-fired generating …
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Adamis Pharmaceuticals Corp (ADMP)-製薬・医療分野:企業M&A・提携分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe …
  • Zecotek Photonics Inc (ZMS):企業の財務・戦略的SWOT分析
    Zecotek Photonics Inc (ZMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Lincoln Electric System:企業の発電所・SWOT分析2018
    Lincoln Electric System - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Dialog Group Bhd (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Bhd (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Noel Gifts International Ltd. (543):企業の財務・戦略的SWOT分析
    Noel Gifts International Ltd. (543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • Hecla Mining Company
    Hecla Mining Company - Strategy, SWOT and Corporate Finance Report Summary Hecla Mining Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Trustees Australia Ltd:企業の戦略・SWOT・財務分析
    Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report Summary Trustees Australia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆